Pooja Mailankody
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Pooja Mailankody has a total of 100 co-authors. Here are the top co-authors by number of shared publications:
Hansashree Padmanabha
Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, Karnataka, 560029, India
7 shared publicationsGautham Arunachal
Department of Human Genetics, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India
5 shared publicationsRohan R. Mahale
Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, Karnataka, 560029, India
5 shared publications- Pramod Kumar Pal
Department of Neurology, National Institute of Mental Health & Neurosciences, Karnataka, India
4 shared publications Rohan Mahale
Department of Neurology, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India
4 shared publications- Rohan Ramachandra Mahale
Department of Neurology, National Institute of Mental Health & Neurosciences (NIMHANS), Bangalore, India
4 shared publications
Latest Publications
- 21 September 2026
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 152, 108990
Not all that ribbons is CJD: A genetic neuropsychiatric mimic
- 21 September 2026
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 152, 108990
Not all that ribbons is CJD: A genetic neuropsychiatric mimic
- 19 August 2026
- Published by Wolters Kluwer Health in Neurology India
Nicotinamide Mononucleotide Adenylyltransferase 2 (NMNAT2) - Related Polyneuropathy - An Unusual Symptom, and a Rare Disease
Was not provided for this article.
- 19 August 2026
- Published by Wolters Kluwer Health in Neurology India
Nicotinamide Mononucleotide Adenylyltransferase 2 (NMNAT2) - Related Polyneuropathy - An Unusual Symptom, and a Rare Disease
Was not provided for this article.
- 10 July 2026
- Published by Springer Nature in Acta Neurologica Belgica
- Vol. 126 (5) , 1845-1848
Peripheral neuropathy as a presenting feature of familial early onset Alzheimer’s disease: a rare clinical association
We describe a patient with genetically confirmed familial early-onset Alzheimer's disease in whom sensory peripheral neuropathy preceded cognitive decline by almost a decade. A 40- year- old man presented with clinical and electrophysiological features of sensory neuropathy, and 9 years later developed memory disturbances. Genetic testing revealed a heterozygous PSEN1 c.349 C > T (p. Pro117Ser) mutation in exon 5. To the best of our knowledge, peripheral neuropathy as an initial manifestation of familial early-onset Alzheimer's disease has never been reported before and could be a possible manifestation of the underlying degenerative process. With this report, we highlight the rarity of this association and underscore the importance of a comprehensive clinical and electrophysiological evaluation in patients with familial early-onset Alzheimer's disease who present with sensory symptoms, gait disturbances, skin or trophic changes, or other clinical features suggestive of peripheral neuropathy.
- 10 July 2026
- Published by Springer Nature in Acta Neurologica Belgica
- Vol. 126 (5) , 1845-1848
Peripheral neuropathy as a presenting feature of familial early onset Alzheimer’s disease: a rare clinical association
We describe a patient with genetically confirmed familial early-onset Alzheimer's disease in whom sensory peripheral neuropathy preceded cognitive decline by almost a decade. A 40- year- old man presented with clinical and electrophysiological features of sensory neuropathy, and 9 years later developed memory disturbances. Genetic testing revealed a heterozygous PSEN1 c.349 C > T (p. Pro117Ser) mutation in exon 5. To the best of our knowledge, peripheral neuropathy as an initial manifestation of familial early-onset Alzheimer's disease has never been reported before and could be a possible manifestation of the underlying degenerative process. With this report, we highlight the rarity of this association and underscore the importance of a comprehensive clinical and electrophysiological evaluation in patients with familial early-onset Alzheimer's disease who present with sensory symptoms, gait disturbances, skin or trophic changes, or other clinical features suggestive of peripheral neuropathy.
- Open Access
- 3 June 2026
- Published by SAGE Publications in Annals of Neurosciences
Retinal Architecture in Parkinson’s Disease with Rapid Eye Movement Sleep Behaviour Disorder: Insights from a Scoping Review
Background: Parkinson’s disease (PD) is the leading age-related neurodegenerative disorder with a deposition of α-synuclein-containing Lewy bodies. Idiopathic REM sleep behaviour disorder (iRBD) can occur a decade prior to motor symptoms onset in PD. The retina acts as a window to the brain and its structural changes, along with RBD, may serve as a prodromal marker for PD. Summary: We evaluated the existing scientific evidence on structural retinal alterations in subjects with iRBD and PD with and without RBD. The selected four studies were observational and investigated the structural retinal layer thickness in iRBD patients, PD patients who likely had RBD (probable RBD), PD lacking RBD, and healthy individuals. Findings reported thinning of the retinal ganglion cell layer, nerve fibre layer (RNFL), outer and inner plexiform layers, inner and outer nuclear layers, reduced ganglion cell complex thickness, and peripapillary RNFL. Additionally, one study reported functional changes, including diminished contrast sensitivity and visual acuity in both the iRBD and PD groups. Key Message: This scoping review highlights significant thinning of retinal layers in RBD subjects in the context of PD. Retinal imaging serves as a biomarker in the early detection of neurodegeneration.
- 3 June 2026
- Published by SAGE Publications in Annals of Neurosciences
Open AccessRetinal Architecture in Parkinson’s Disease with Rapid Eye Movement Sleep Behaviour Disorder: Insights from a Scoping Review
Background: Parkinson’s disease (PD) is the leading age-related neurodegenerative disorder with a deposition of α-synuclein-containing Lewy bodies. Idiopathic REM sleep behaviour disorder (iRBD) can occur a decade prior to motor symptoms onset in PD. The retina acts as a window to the brain and its structural changes, along with RBD, may serve as a prodromal marker for PD. Summary: We evaluated the existing scientific evidence on structural retinal alterations in subjects with iRBD and PD with and without RBD. The selected four studies were observational and investigated the structural retinal layer thickness in iRBD patients, PD patients who likely had RBD (probable RBD), PD lacking RBD, and healthy individuals. Findings reported thinning of the retinal ganglion cell layer, nerve fibre layer (RNFL), outer and inner plexiform layers, inner and outer nuclear layers, reduced ganglion cell complex thickness, and peripapillary RNFL. Additionally, one study reported functional changes, including diminished contrast sensitivity and visual acuity in both the iRBD and PD groups. Key Message: This scoping review highlights significant thinning of retinal layers in RBD subjects in the context of PD. Retinal imaging serves as a biomarker in the early detection of neurodegeneration.
- 7 May 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (6) , 474
Optical coherence tomography is a useful tool for monitoring treatment response in migraine: a prospective longitudinal study
Background and objectives Migraine is a primary headache disorder wherein vascular changes are well known. We aimed to evaluate the retinal and choroidal parameters in migraine patients longitudinally, with a particular focus on treatment-related changes. Methods We conducted a prospective longitudinal study of 45 patients with migraine (ICHD-3 criteria) who were indicated for prophylactic treatment. The patients were evaluated clinically using the visual analogue scale (VAS), monthly migraine days (MMD), migraine disability assessment score (MIDAS), and Optical Coherence Tomography (OCT) at baseline and after 3 months of follow-up. The peripapillary retinal nerve fibre layer (PPRNFL), peripapillary choroid thickness (PPCHT), subfoveal choroid thickness (SFC), ganglion cell layer (GCL), and central macular thickness (CMT) were the parameters assessed using OCT. 45 age- and gender-matched healthy controls were recruited for comparison of baseline parameters. Results The majority of patients (38/45) were females, and the mean age was 37.3 ± 10.0 years. The PPRNFL, PPCHT, SFC LE, GCL, and CMT were thinner in patients than in controls. All parameters, except the GCL and CMT, increased significantly during follow-up after 3 months of prophylactic treatment. Conclusion This longitudinal study demonstrated partial structural recovery, suggesting that some retinal and choroidal changes in migraine may be reversible. Our findings support the role of these OCT parameters as surrogate markers of disease burden and treatment response in migraine. Large-scale, multicentre prospective studies with longer follow-up are warranted to evaluate the prognostic utility of OCT parameters in migraine.
- 7 May 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (6) , 474
Optical coherence tomography is a useful tool for monitoring treatment response in migraine: a prospective longitudinal study
Background and objectives Migraine is a primary headache disorder wherein vascular changes are well known. We aimed to evaluate the retinal and choroidal parameters in migraine patients longitudinally, with a particular focus on treatment-related changes. Methods We conducted a prospective longitudinal study of 45 patients with migraine (ICHD-3 criteria) who were indicated for prophylactic treatment. The patients were evaluated clinically using the visual analogue scale (VAS), monthly migraine days (MMD), migraine disability assessment score (MIDAS), and Optical Coherence Tomography (OCT) at baseline and after 3 months of follow-up. The peripapillary retinal nerve fibre layer (PPRNFL), peripapillary choroid thickness (PPCHT), subfoveal choroid thickness (SFC), ganglion cell layer (GCL), and central macular thickness (CMT) were the parameters assessed using OCT. 45 age- and gender-matched healthy controls were recruited for comparison of baseline parameters. Results The majority of patients (38/45) were females, and the mean age was 37.3 ± 10.0 years. The PPRNFL, PPCHT, SFC LE, GCL, and CMT were thinner in patients than in controls. All parameters, except the GCL and CMT, increased significantly during follow-up after 3 months of prophylactic treatment. Conclusion This longitudinal study demonstrated partial structural recovery, suggesting that some retinal and choroidal changes in migraine may be reversible. Our findings support the role of these OCT parameters as surrogate markers of disease burden and treatment response in migraine. Large-scale, multicentre prospective studies with longer follow-up are warranted to evaluate the prognostic utility of OCT parameters in migraine.
- 4 May 2026
- Published by Springer Nature in The Cerebellum
- Vol. 25 (3) , 70
Clinical and Genetic Profile of Gordon-Holmes Syndrome: A Review of Published Cases
Gordon Holmes syndrome (GHS, MIM 212840) is an autosomal recessive disorder with a clinical manifestation of cerebellar ataxia, dementia and hypogonadotropic hypogonadism. To describe the clinical and genetic profile of patients with GHS reported worldwide with genotype-phenotype correlation. This is a review of reported cases of GHS based on the different genetic variant worldwide. We report 2 patients of GHS due to variant in the RNF216 gene. There was total 29 reported cases of GHS with RNF216 variants, 9 cases with PNPLA6 variants, and 5 with STUB1 variant. There was male predominance in the RNF216 and PNPLA6 variants. The median age at onset was lower and duration of illness was longer in STUB1 variants. Cerebellar ataxia and dysarthria were seen in all variants. Dementia, chorea and psychiatric disturbances were common in RNF216 variants. Seizures were seen only in STUB1 variants. Hypogonadotrophic hypogonadism were seen in all variants. Brain magnetic resonance imaging showed signal changes in the white matter apart from the cerebellar and cerebral atrophy in RNF216 variants. Missense, frameshift and non-sense variants were common in RNF216 and missense variants were common in PNPLA6 and STUB1. The phenotypic and genotypic presentation of GHS is heterogeneous with variants in the RNF216 representing majority of GHS cases.
- 4 May 2026
- Published by Springer Nature in The Cerebellum
- Vol. 25 (3) , 70
Clinical and Genetic Profile of Gordon-Holmes Syndrome: A Review of Published Cases
Gordon Holmes syndrome (GHS, MIM 212840) is an autosomal recessive disorder with a clinical manifestation of cerebellar ataxia, dementia and hypogonadotropic hypogonadism. To describe the clinical and genetic profile of patients with GHS reported worldwide with genotype-phenotype correlation. This is a review of reported cases of GHS based on the different genetic variant worldwide. We report 2 patients of GHS due to variant in the RNF216 gene. There was total 29 reported cases of GHS with RNF216 variants, 9 cases with PNPLA6 variants, and 5 with STUB1 variant. There was male predominance in the RNF216 and PNPLA6 variants. The median age at onset was lower and duration of illness was longer in STUB1 variants. Cerebellar ataxia and dysarthria were seen in all variants. Dementia, chorea and psychiatric disturbances were common in RNF216 variants. Seizures were seen only in STUB1 variants. Hypogonadotrophic hypogonadism were seen in all variants. Brain magnetic resonance imaging showed signal changes in the white matter apart from the cerebellar and cerebral atrophy in RNF216 variants. Missense, frameshift and non-sense variants were common in RNF216 and missense variants were common in PNPLA6 and STUB1. The phenotypic and genotypic presentation of GHS is heterogeneous with variants in the RNF216 representing majority of GHS cases.
- Open Access
- 24 March 2026
- Published by Springer Nature in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
- Vol. 62 (1) , 78
Clinico-radiological spectrum of neurological involvement in scrub typhus: insights from 17 cases at a Quaternary Care Centre
Objective: We evaluate the clinical and radiological features, as well as the outcomes, of neurological disorders associated with scrub typhus. Methods: This is a retrospective, cross-sectional study from South India, from January 2020 to January 2023. Patients presented with meningoencephalitis, cerebellitis, rhombencephalitis, vasculitis, and opsoclonus myoclonus ataxia syndrome (OMAS). A late complication of polyradiculopathy was also observed. The investigations included cerebrospinal fluid (CSF) examination and magnetic resonance imaging (MRI) brain. Results: Seventeen patients with scrub typhus-associated neurological disorders were included, with a mean age of 31.6 ± 13.1 years, and two-thirds were males. The majority of patients had lymphocytic pleocytosis in CSF and raised protein. Brain MRI changes included meningeal enhancement, acute infarcts, and alterations in the brainstem and cerebellum. All patients received doxycycline and the majority showed improvement at follow-up. Conclusion: Scrub typhus-associated neurological disorders commonly present as meningitis, encephalitis, or meningoencephalitis, with lymphocytic pleocytosis and raised protein in CSF. We expand the spectrum to include CNS vasculitis- like picture, rhombencephalitis, OMAS and a hitherto unreported late complication of polyradiculopathy. Early diagnosis and prompt treatment with doxycycline and supportive care can lead to favorable outcomes.
- 24 March 2026
- Published by Springer Nature in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
- Vol. 62 (1) , 78
Open AccessClinico-radiological spectrum of neurological involvement in scrub typhus: insights from 17 cases at a Quaternary Care Centre
Objective: We evaluate the clinical and radiological features, as well as the outcomes, of neurological disorders associated with scrub typhus. Methods: This is a retrospective, cross-sectional study from South India, from January 2020 to January 2023. Patients presented with meningoencephalitis, cerebellitis, rhombencephalitis, vasculitis, and opsoclonus myoclonus ataxia syndrome (OMAS). A late complication of polyradiculopathy was also observed. The investigations included cerebrospinal fluid (CSF) examination and magnetic resonance imaging (MRI) brain. Results: Seventeen patients with scrub typhus-associated neurological disorders were included, with a mean age of 31.6 ± 13.1 years, and two-thirds were males. The majority of patients had lymphocytic pleocytosis in CSF and raised protein. Brain MRI changes included meningeal enhancement, acute infarcts, and alterations in the brainstem and cerebellum. All patients received doxycycline and the majority showed improvement at follow-up. Conclusion: Scrub typhus-associated neurological disorders commonly present as meningitis, encephalitis, or meningoencephalitis, with lymphocytic pleocytosis and raised protein in CSF. We expand the spectrum to include CNS vasculitis- like picture, rhombencephalitis, OMAS and a hitherto unreported late complication of polyradiculopathy. Early diagnosis and prompt treatment with doxycycline and supportive care can lead to favorable outcomes.
- Open Access
- 27 February 2026
- Published by Wolters Kluwer Health in Annals of Indian Academy of Neurology
- Vol. 29 (3) , 478-480
Headache in a Patient with Anti-Leucine-Rich Glioma Inactivated 1 Autoimmune Encephalitis Responding to Rituximab
An abstract is unavailable. This article is available as a PDF only.
- 27 February 2026
- Published by Wolters Kluwer Health in Annals of Indian Academy of Neurology
- Vol. 29 (3) , 478-480
Open AccessHeadache in a Patient with Anti-Leucine-Rich Glioma Inactivated 1 Autoimmune Encephalitis Responding to Rituximab
An abstract is unavailable. This article is available as a PDF only.
- Open Access
- 1 January 2026
- Published by Wiley in Acta Neurologica Scandinavica
- Vol. 2026 (1) , 2596557
Nutritional Deficiency as a Risk Factor for Cerebral Venous Thrombosis in Parts of Southern India: A Case‐Control Study
The incidence of cerebral venous thrombosis (CVT) is anecdotally considered to be higher in parts of South India as compared with the West. The higher prevalence of CVT in this population is not accounted for by genetic thrombophilias, implicating acquired risk factors. As hyperhomocysteinemia and vitamin B12 deficiency are common in this population, we expected unique risk factors related to the diet. This case‐control study was done to examine the acquired risk factors and dietary patterns in these patients. Patients with CVT admitted from June 2021 to January 2023 were included in the study. Healthy attendants of other patients attending the emergency department for other neurological illnesses were recruited as controls. Clinical and biochemical data of patients were collected. Diet was assessed using a food frequency questionnaire. The contribution of food items to various nutrients (calories, protein, methionine, vitamin B12, folate, pyridoxine, and riboflavin) was calculated and compared with the recommended dietary allowance (RDA) and controls. The study enrolled 104 patients and 109 controls. The mean age of patients was 34.9 years (SD = 13.4). Hyperhomocysteinemia, anemia, alcohol consumption, folate deficiency, and vitamin B12 deficiency were observed in 63.5%, 46.2%, 45.2%, 37.5%, and 26%, respectively. Patients with a history of alcohol consumption had significantly higher homocysteine and lower folate. The diet of the patients had significantly higher odds of being protein‐deficient and folate‐deficient as compared with controls on multiple linear regression analysis. Poor nutrition, in the form of hyperhomocysteinemia and anemia, was the most common risk factor in the study population. Crucially, these risk factors are modifiable. Further large‐scale studies are needed to determine the incidence of CVT in this area and to evaluate the role of dietary interventions for risk modification.
- 1 January 2026
- Published by Wiley in Acta Neurologica Scandinavica
- Vol. 2026 (1) , 2596557
Open AccessNutritional Deficiency as a Risk Factor for Cerebral Venous Thrombosis in Parts of Southern India: A Case‐Control Study
The incidence of cerebral venous thrombosis (CVT) is anecdotally considered to be higher in parts of South India as compared with the West. The higher prevalence of CVT in this population is not accounted for by genetic thrombophilias, implicating acquired risk factors. As hyperhomocysteinemia and vitamin B12 deficiency are common in this population, we expected unique risk factors related to the diet. This case‐control study was done to examine the acquired risk factors and dietary patterns in these patients. Patients with CVT admitted from June 2021 to January 2023 were included in the study. Healthy attendants of other patients attending the emergency department for other neurological illnesses were recruited as controls. Clinical and biochemical data of patients were collected. Diet was assessed using a food frequency questionnaire. The contribution of food items to various nutrients (calories, protein, methionine, vitamin B12, folate, pyridoxine, and riboflavin) was calculated and compared with the recommended dietary allowance (RDA) and controls. The study enrolled 104 patients and 109 controls. The mean age of patients was 34.9 years (SD = 13.4). Hyperhomocysteinemia, anemia, alcohol consumption, folate deficiency, and vitamin B12 deficiency were observed in 63.5%, 46.2%, 45.2%, 37.5%, and 26%, respectively. Patients with a history of alcohol consumption had significantly higher homocysteine and lower folate. The diet of the patients had significantly higher odds of being protein‐deficient and folate‐deficient as compared with controls on multiple linear regression analysis. Poor nutrition, in the form of hyperhomocysteinemia and anemia, was the most common risk factor in the study population. Crucially, these risk factors are modifiable. Further large‐scale studies are needed to determine the incidence of CVT in this area and to evaluate the role of dietary interventions for risk modification.
- Open Access
- 31 October 2025
- Published by The Korean Movement Disorder Society in Journal of Movement Disorders
- Vol. 18 (4) , 389-392
Revisiting the Triglyceride–Glucose Index in Parkinson’s Disease: Risk Ractor or Disease Marker?
Revisiting the triglyceride-glucose index in Parkinson’s disease: Risk factor or disease marker?
- 31 October 2025
- Published by The Korean Movement Disorder Society in Journal of Movement Disorders
- Vol. 18 (4) , 389-392
Open AccessRevisiting the Triglyceride–Glucose Index in Parkinson’s Disease: Risk Ractor or Disease Marker?
Revisiting the triglyceride-glucose index in Parkinson’s disease: Risk factor or disease marker?